ArticleFrontiers in bioengineering and biotechnology2025
Total potentiation level: a new metric for quantifying post-activation potentiation dynamics using tensiomyography and statistical parametric mapping.
Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Post-activation potentiation (PAP), a transient increase in muscle twitch force after conditioning stimuli, may influence performance. Traditional discrete metrics often fail to resolve PAP's time-dependent contractility changes. We introduce Total Potentiation Level (TPL)-the integrated area of significant potentiation over time derived from statistical parametric mapping (SPM) of tensiomyography (TMG) data in the rectus femoris-to quantify PAP holistically. We hypothesized that this romisingSPM-based TPL approach would more sensitively capture PAP's temporal dynamics than traditional discrete measures. Methods: Fifty-eight physically active adults (36M/22F; 28.4 ± 11.0 years; normalized knee torque 1.395 ± 0.158Nm/kg) performed four sets of eight incline squats (ISQ) with individualized loads (10RM-based) and 150-s inter-set rest. TMG assessed rectus femoris twitch responses pre/post-ISQ. SPM analyzed potentiation profiles, with TPL derived from supra-threshold SPM t-continuum. TPL's sensitivity to PAP dynamics was compared to traditional discrete metrics. Results: SPM analysis indicated that potentiation was maximized following the second ISQ set (TPL = 636.5; p < 0.0001), then plateaued with a slight decline by the fourth set. Statistically significant temporal changes in PAP were observed between 11.3 m and 62.6 m, a detail not discernible through conventional discrete measures. This suggests that TPL may offer enhanced sensitivity in identifying peak potentiation and early fatigue onset. Discussion: The findings suggest that TMG combined with SPM provides an approach for PAP quantification, with TPL potentially offering a comprehensive view of potentiation dynamics. TPL captures nuanced, continuous temporal changes not readily apparent in traditional discrete analyses and may inform more precise conditioning strategies. Further research is warranted to confirm these preliminary observations and explore broader applications. Conclusion: We developed TPL by combining tensiomyography TMG and statistical parametric mapping SPM. TPL uses SPM's dynamic time-amplitude analysis to detect subtle, transient PAP shifts, enabling precise neuromuscular adaptation quantification. Its applications may span training, rehabilitation, and aging-related interventions by potentially optimizing conditioning parameters to enhance muscle contractility with minimal fatigue. TPL could also help identify optimal individualized loads to maximize contractile performance, with potential benefits for athletic and therapeutic outcomes and load management. Further studies are needed to validate TPL across various exercise modalities and populations, thereby increasing its applicability to tailored applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.